These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 35280112)

  • 1. A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer.
    Yao JM; Zhao JY; Lv FF; Yang XB; Wang HJ
    Pathol Oncol Res; 2022; 28():1610012. PubMed ID: 35280112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer.
    Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram.
    Chen F; Li Z; Deng C; Yan H
    J Cell Biochem; 2019 Dec; 120(12):19673-19683. PubMed ID: 31271223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cell cycle-related lncRNA signature predicts the progression-free interval in papillary thyroid carcinoma.
    Li S; Ran MY; Qiao H
    Front Endocrinol (Lausanne); 2023; 14():1110987. PubMed ID: 36923215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer.
    Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T
    Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential LncRNAs as papillary thyroid carcinoma biomarkers based on integrated bioinformatics analysis using TCGA and RNA sequencing data.
    Feng JL; Zheng WJ; Xu L; Zhou QY; Chen J
    Sci Rep; 2023 Mar; 13(1):4350. PubMed ID: 36928327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma.
    Huang Y; Li X; Chen W; He Y; Wu S; Li X; Hou B; Wang S; He Y; Jiang H; Lun Y; Zhang J
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108286. PubMed ID: 34735975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Potential Four-Gene Signature and Nomogram for Predicting the Overall Survival of Papillary Thyroid Cancer.
    Ding Y; Li P; Wang W; Liu F
    Dis Markers; 2022; 2022():8735551. PubMed ID: 36193505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of immune-related lncRNAs to improve the prognosis prediction for patients with papillary thyroid cancer.
    Li Z; Lin W; Zheng J; Hong W; Zou J; Zhang T; Chen Y; Lu H
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33554245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
    Li Q; Li H; Zhang L; Zhang C; Yan W; Wang C
    Oncotarget; 2017 Jul; 8(28):46136-46144. PubMed ID: 28545026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of lncRNA-miRNA-mRNA interactions identified a novel biomarker LINC00657 to improve prognosis prediction of papillary thyroid carcinoma.
    Li S; Wang M; Liu B; Lv Y; Man J; Liang M; Qiao H
    Int Immunopharmacol; 2024 Aug; 137():112432. PubMed ID: 38865751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer.
    Xia M; Wang S; Wang L; Mei Y; Tu Y; Gao L
    Front Endocrinol (Lausanne); 2023; 14():1062317. PubMed ID: 37025405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
    Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K
    Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Hub lncRNAs Along With lncRNA-miRNA-mRNA Network for Effective Diagnosis and Prognosis of Papillary Thyroid Cancer.
    Li H; Liu F; Wang X; Li M; Li Z; Xie Y; Guo Y
    Front Pharmacol; 2021; 12():748867. PubMed ID: 34721037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
    Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
    Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.